The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.
COVID-19
END TB Strategy
MDR/XDR-TB
New tools
Tuberculosis
WHO 2021 Global TB Report
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
10
02
2022
revised:
07
03
2022
accepted:
07
03
2022
pubmed:
25
3
2022
medline:
15
12
2022
entrez:
24
3
2022
Statut:
ppublish
Résumé
To review the data presented in the 2021 WHO global TB report and discuss the current constraints in the global response. The WHO global TB reports, consolidate TB data from countries and provide up to date assessment of the global TB epidemic. We reviewed the data presented in the 2021 report. We noted that the 2021 WHO global TB report presents a rather grim picture on the trajectory of the global epidemic of TB including a stagnation in the annual decline in TB incidence, a decline in TB notifications and an increase in estimated TB deaths. All the targets set at the 2018 United Nations High Level Meeting on TB were off track. The sub-optimal global performance on achieving TB control targets in 2020 is attributed to the on-going COVID-19 pandemic, however, TB programs were already off track well before the onset of the pandemic, suggesting that the pandemic amplified an already fragile global TB response. We emphasize that ending the global TB epidemic will require bold leadership, optimization of existing interventions, widespread coverage, addressing social determinants of TB and importantly mobilization of adequate funding required for TB care and prevention.
Identifiants
pubmed: 35321845
pii: S1201-9712(22)00149-7
doi: 10.1016/j.ijid.2022.03.011
pmc: PMC8934249
pii:
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S26-S29Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.
Références
Eur Respir J. 2021 Jun 4;57(6):
pubmed: 33243847
Public Health Rep (1896). 1961 Jan;76:19-24
pubmed: 13694948
J Bras Pneumol. 2018 Apr;44(2):134-144
pubmed: 29791553
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
Eur Respir J. 2022 Mar 24;59(3):
pubmed: 34764184
Pulmonology. 2021 Mar-Apr;27(2):151-165
pubmed: 33547029
Vaccines (Basel). 2021 May 21;9(6):
pubmed: 34063863
Eur Respir J. 2015 Apr;45(4):928-52
pubmed: 25792630
Lancet. 2010 Oct 9;376(9748):1244-53
pubmed: 20923715
Math Biosci. 2012 Apr;236(2):77-96
pubmed: 22387570
Eur Respir J. 2021 Nov 11;58(5):
pubmed: 34446465
Front Immunol. 2020 Oct 08;11:566608
pubmed: 33117351
Afr J Lab Med. 2021 Jun 17;10(1):1413
pubmed: 34230879
Methods Mol Biol. 2022;2410:387-409
pubmed: 34914059
Int Health. 2015 Mar;7(2):114-20
pubmed: 25733561
Int J Infect Dis. 2021 Dec;113 Suppl 1:S100-S103
pubmed: 33716198
Int J Infect Dis. 2021 Dec;113 Suppl 1:S1-S6
pubmed: 33746094
J Prev Med Hyg. 2017 Mar;58(1):E9-E12
pubmed: 28515626